Proposed Data Collections Submitted for Public Comment and Recommendations, 7855-7856 [2011-3079]

Download as PDF Federal Register / Vol. 76, No. 29 / Friday, February 11, 2011 / Notices provides for the formation of PSO5, which collect, aggregate, and analyze confidential information regarding the quality and safety of health care delivery. The Patient Safety and Quality Improvement Final Rule (Patient Safety Rule), 42 CFR part 3, authorizes AHRQ, on behalf of the Secretary of HHS, to list as a PSO an entity that attests that it meets the statutory and regulatory requirements for listing. A PSO can be ‘‘delisted’’ by the Secretary if it is found to no longer meet the requirements of the Patient Safety Act and Patient Safety Rule, including when a PSO chooses to voluntarily relinquish its status as a PSO for any reason. DATES: The directories for both listed and delisted PSOs are ongoing and reviewed weekly by AHRQ. The delisting was effective at 12 Midnight ET (2400) on December 7, 2010. ADDRESSES: Both directories can be accessed electronically at the following HHS Web site: https://www.pso. AHRQ.gov/. FOR FURTHER INFORMATION CONTACT: Diane Cousins, RPh., Center for Quality Improvement and Patient Safety, AHRQ, 540 Gaither Road, Rockville, MD 20850; Telephone (toll free): (866) 403–3697; Telephone (local): (301) 427–1111; TTY (toll free): (866) 438–7231; TTY (local): (301) 427–1130; E-mail: pso@AHRQ. hhs.gov. SUPPLEMENTARY INFORMATION: jlentini on DSKJ8SOYB1PROD with NOTICES Background The Patient Safety Act authorizes the listing of PSOs, which are entities or component organizations whose mission and primary activity is to conduct activities to improve patient safety and the quality of health care delivery. HHS issued the Patient Safety Rule to implement the Patient Safety Act. AHRQ administers the provisions of the Patient Safety Act and Patient Safety Rule (PDF file, 450 KB. PDF Help) relating to the listing and operation of PSOs. Section 3.108(d) of the Patient Safety Rule requires AHRQ to provide public notice when it removes an organization from the list of Federally approved PSOs. AHRQ has accepted a notification from Lumetra PSO, a component entity of Lumetra Healthcare Solutions, PSO number P0033, to voluntarily relinquish its status as a PSO. Accordingly, Lumetra PSO, a component entity of Lumetra Healthcare Solutions, was delisted effective at 12 Midnight ET (2400) on December 7, 2010. More information on PSOs can be obtained through AHRQ’s P50 Web site at https://www.pso. AHRQ.gov/. VerDate Mar<15>2010 18:55 Feb 10, 2011 Jkt 223001 Dated: January 28, 2011. Carolyn M. Clancy, Director. [FR Doc. 2011–2912 Filed 2–10–11; 8:45 am] BILLING CODE 4160–90–M DEPARTMENT OF HEALTH AND HUMAN SERVICES Agency for Healthcare Research and Quality Patient Safety Organizations: Voluntary Delisting From Community Medical Foundation for Patient Safety Agency for Healthcare Research and Quality (AHRQ), HHS. ACTION: Notice of Delisting. AGENCY: Community Medical Foundation for Patient Safety: AHRQ has accepted a notification of voluntary relinquishment from Community Medical Foundation for Patient Safety, of its status as a Patient Safety Organization (PSO). The Patient Safety and Quality Improvement Act of 2005 (Patient Safety Act), Public Law 109– 41,42 U.S.C. 299b–21—b–26, provides for the formation of PSOs, which collect, aggregate, and analyze confidential information regarding the quality and safety of health care delivery. The Patient Safety and Quality Improvement Final Rule (Patient Safety Rule), 42 CFR Part 3, authorizes AHRQ, on behalf of the Secretary of HHS, to list as a PSO an entity that attests that it meets the statutory and regulatory requirements for listing. A PSO can be ‘‘delisted’’ by the Secretary if it is found to no longer meet the requirements of the Patient Safety Act and Patient Safety Rule, including when a PSO chooses to voluntarily relinquish its status as a PSO for any reason. DATES: The directories for both listed and delisted PSOs are ongoing and reviewed weekly by AHRQ. The delisting was effective at 12 Midnight ET (2400) on December 22, 2010. ADDRESSES: Both directories can be accessed electronically at the following HHS Web site: https:// www.pso.AHRQ.gov/. FOR FURTHER INFORMATION CONTACT: Diane Cousins, RPh., Center for Quality Improvement and Patient Safety, AHRQ, 540 Gaither Road, Rockville, MD 20850; Telephone (toll free): (866) 403–3697; Telephone (local): (301) 427–1111; TTY (toll free): (866) 438–7231; TTY (local): (301) 427–1130; E-mail: pso@AHRQ.hhs.gov. SUMMARY: SUPPLEMENTARY INFORMATION: PO 00000 Frm 00049 Fmt 4703 Sfmt 4703 7855 Background The Patient Safety Act authorizes the listing of PSOs, which are entities or component organizations whose mission and primary activity is to conduct activities to improve patient safety and the quality of health care delivery. HHS issued the Patient Safety Rule to implement the Patient Safety Act. AHRQ administers the provisions of the Patient Safety Act and Patient Safety Rule (PDF file, 450 KB. PDF Help) relating to the listing and operation of PSOs. Section 3.108(d) of the Patient Safety Rule requires AHRQ to provide public notice when it removes an organization from the list of federally approved PSOs. AHRQ has accepted a notification from Community Medical Foundation for Patient Safety, PSO number P0029, to voluntarily relinquish its status as a PSO. Accordingly, Community Medical Foundation for Patient Safety was delisted effective at 12 Midnight ET (2400) on December 22, 2010. More information on PSOs can be obtained through AHRQ’s PSO Web site at https://www.pso.AHRQ.gov/ index.html. Dated: January 28, 2011. Carolyn M. Clancy, Director. [FR Doc. 2011–2910 Filed 2–10–11; 8:45 am] BILLING CODE 4160–90–M DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention [60Day–11–0026] Proposed Data Collections Submitted for Public Comment and Recommendations In compliance with the requirement of Section 3506(c)(2)(A) of the Paperwork Reduction Act of 1995 for opportunity for public comment on proposed data collection projects, the Centers for Disease Control and Prevention (CDC) will publish periodic summaries of proposed projects. To request more information on the proposed projects or to obtain a copy of the data collection plans and instruments, call 404–639–5960 and send comments to Carol E. Walker, CDC Acting Reports Clearance Officer, 1600 Clifton Road, MS–D74, Atlanta, GA 30333 or send an e-mail to omb@cdc.gov. Comments are invited on: (a) Whether the proposed collection of information is necessary for the proper performance E:\FR\FM\11FEN1.SGM 11FEN1 7856 Federal Register / Vol. 76, No. 29 / Friday, February 11, 2011 / Notices State and Territorial Epidemiologists, and the Advisory Committee for the Elimination of Tuberculosis. No revisions to the RVCT are proposed in this data collection extension request. CDC publishes an annual report using RVCT data to summarize national TB statistics and also periodically conducts special analyses for publication to further describe and interpret national TB data. These data assist in public health planning, evaluation, and resource allocation. Reporting areas also review and analyze their RVCT data to monitor local TB trends, evaluate program success, and focus resources to eliminate TB. No other Federal agency collects this type of national TB data. In addition to providing technical assistance on the use of RVCT, CDC provides technical support for reporting software. In this request, CDC is requesting approval for approximately 6,720 burden hours, an estimated decrease of 1,330 hours. This decrease is due to having fewer TB cases in the United States as we continue progress towards TB elimination. There is no cost to respondents except for their time. in their lives. The purpose of this project is to continue ongoing national tuberculosis surveillance using the standardized Report of Verified Case of Tuberculosis (RVCT). Data collected using the RVCT help State and Federal infectious disease officials to assess changes in the diagnosis and treatment of TB, monitor trends in TB epidemiology and outbreaks, and develop strategies to meet the national goal of TB elimination. CDC currently conducts and maintains the national surveillance system pursuant to the provisions of section 301(a) of the Public Service Act [42 U.S.C. 241] and section 306 of the Public Service Act [42 U.S.C. 241(a)]. Data are collected by 60 reporting areas (the 50 States, the District of Columbia, New York City, Puerto Rico, and 7 jurisdictions in the Pacific and Caribbean). The last major revision of the RVCT data collection instrument was approved in 2008, in consultation with CDC’s Division of Tuberculosis Elimination (DTBE), State and local health departments, and partner organizations including the National TB Controllers Association, the Council for of the functions of the agency, including whether the information shall have practical utility; (b) the accuracy of the agency’s estimate of the burden of the proposed collection of information; (c) ways to enhance the quality, utility, and clarity of the information to be collected; and (d) ways to minimize the burden of the collection of information on respondents, including through the use of automated collection techniques or other forms of information technology. Written comments should be received within 60 days of this notice. Proposed Project Report of Verified Case of Tuberculosis (RVCT), (OMB No.0920– 0026 exp. 5/31/2011)—Extension— National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (NCHHSTP), Centers for Disease Control and Prevention (CDC). Background and Brief Description In the United States, an estimated 10 to 15 million people are infected with Mycobacterium tuberculosis and about 10% of these persons will develop tuberculosis (TB) disease at some point ESTIMATE OF ANNUALIZED BURDEN HOURS Number of respondents Types of respondents Number of responses per respondent Average burden response (in hours) Total burden (in hours) Local, State, and territorial health departments .............................................. 60 192 35/60 6,720 Total .......................................................................................................... ........................ ........................ ........................ 6,720 Dated: February 4, 2011. Carol E. Walker, Acting Reports Clearance Officer, Centers for Disease Control and Prevention. [FR Doc. 2011–3079 Filed 2–10–11; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention [60Day–11–11CC] jlentini on DSKJ8SOYB1PROD with NOTICES Proposed Data Collections Submitted for Public Comment and Recommendations In compliance with the requirement of Section 3506(c)(2)(A) of the Paperwork Reduction Act of 1995 for opportunity for public comment on proposed data collection projects, the Centers for Disease Control and Prevention (CDC) will publish periodic VerDate Mar<15>2010 18:55 Feb 10, 2011 Jkt 223001 summaries of proposed projects. To request more information on the proposed projects or to obtain a copy of the data collection plans and instruments, call 404–639–5960 or send comments to Carol E. Walker, CDC Acting Reports Clearance Officer, 1600 Clifton Road, MS D–74, Atlanta, GA 30333 or send an e-mail to omb@cdc.gov. Comments are invited on: (a) Whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information shall have practical utility; (b) the accuracy of the agency’s estimate of the burden of the proposed collection of information; (c) ways to enhance the quality, utility, and clarity of the information to be collected; and (d) ways to minimize the burden of the collection of information on respondents, including through the use of automated collection techniques or other forms of information technology. Written comments should PO 00000 Frm 00050 Fmt 4703 Sfmt 4703 be received within 60 days of this notice. Proposed Project Development and Evaluation of Eagle Books and Youth Eagle Books for American Indians and Alaska Natives (AI/ANs)—New—National Center for Chronic Disease Prevention and Health Promotion (NCCDPHP), Centers for Disease Control and Prevention (CDC). Background and Brief Description The development of effective diabetes prevention programs targeting AI/AN youth is a compelling priority in education and public health. AI/ANs develop type 2 diabetes at younger ages, experience more years of disease burden and have a high probability of developing diabetes-related complications. However, research shows that type 2 diabetes can be prevented or delayed with healthy foods, moderate physical activity, and social support. A number of health E:\FR\FM\11FEN1.SGM 11FEN1

Agencies

[Federal Register Volume 76, Number 29 (Friday, February 11, 2011)]
[Notices]
[Pages 7855-7856]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-3079]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[60Day-11-0026]

Proposed Data Collections Submitted for Public Comment and
Recommendations

In compliance with the requirement of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for opportunity for public comment on
proposed data collection projects, the Centers for Disease Control and
Prevention (CDC) will publish periodic summaries of proposed projects.
To request more information on the proposed projects or to obtain a
copy of the data collection plans and instruments, call 404-639-5960
and send comments to Carol E. Walker, CDC Acting Reports Clearance
Officer, 1600 Clifton Road, MS-D74, Atlanta, GA 30333 or send an e-mail
to omb@cdc.gov.
Comments are invited on: (a) Whether the proposed collection of
information is necessary for the proper performance

[[Page 7856]]

of the functions of the agency, including whether the information shall
have practical utility; (b) the accuracy of the agency's estimate of
the burden of the proposed collection of information; (c) ways to
enhance the quality, utility, and clarity of the information to be
collected; and (d) ways to minimize the burden of the collection of
information on respondents, including through the use of automated
collection techniques or other forms of information technology. Written
comments should be received within 60 days of this notice.

Proposed Project

Report of Verified Case of Tuberculosis (RVCT), (OMB No.0920-0026
exp. 5/31/2011)--Extension--National Center for HIV/AIDS, Viral
Hepatitis, STD, and TB Prevention (NCHHSTP), Centers for Disease
Control and Prevention (CDC).

Background and Brief Description

In the United States, an estimated 10 to 15 million people are
infected with Mycobacterium tuberculosis and about 10% of these persons
will develop tuberculosis (TB) disease at some point in their lives.
The purpose of this project is to continue ongoing national
tuberculosis surveillance using the standardized Report of Verified
Case of Tuberculosis (RVCT). Data collected using the RVCT help State
and Federal infectious disease officials to assess changes in the
diagnosis and treatment of TB, monitor trends in TB epidemiology and
outbreaks, and develop strategies to meet the national goal of TB
elimination.
CDC currently conducts and maintains the national surveillance
system pursuant to the provisions of section 301(a) of the Public
Service Act [42 U.S.C. 241] and section 306 of the Public Service Act
[42 U.S.C. 241(a)]. Data are collected by 60 reporting areas (the 50
States, the District of Columbia, New York City, Puerto Rico, and 7
jurisdictions in the Pacific and Caribbean). The last major revision of
the RVCT data collection instrument was approved in 2008, in
consultation with CDC's Division of Tuberculosis Elimination (DTBE),
State and local health departments, and partner organizations including
the National TB Controllers Association, the Council for State and
Territorial Epidemiologists, and the Advisory Committee for the
Elimination of Tuberculosis. No revisions to the RVCT are proposed in
this data collection extension request.
CDC publishes an annual report using RVCT data to summarize
national TB statistics and also periodically conducts special analyses
for publication to further describe and interpret national TB data.
These data assist in public health planning, evaluation, and resource
allocation. Reporting areas also review and analyze their RVCT data to
monitor local TB trends, evaluate program success, and focus resources
to eliminate TB. No other Federal agency collects this type of national
TB data. In addition to providing technical assistance on the use of
RVCT, CDC provides technical support for reporting software.
In this request, CDC is requesting approval for approximately 6,720
burden hours, an estimated decrease of 1,330 hours. This decrease is
due to having fewer TB cases in the United States as we continue
progress towards TB elimination. There is no cost to respondents except
for their time.

Estimate of Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Average
Number of Number of burden Total burden
Types of respondents respondents responses per response (in (in hours)
respondent hours)
----------------------------------------------------------------------------------------------------------------
Local, State, and territorial health departments 60 192 35/60 6,720
---------------------------------------------------------------
Total....................................... .............. .............. .............. 6,720
----------------------------------------------------------------------------------------------------------------

Dated: February 4, 2011.
Carol E. Walker,
Acting Reports Clearance Officer, Centers for Disease Control and
Prevention.
[FR Doc. 2011-3079 Filed 2-10-11; 8:45 am]
BILLING CODE 4163-18-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.